A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1

✍ Scribed by P.S. Kishnani; M. DiRocco; P. Kaplan; A. Mehta; G.M. Pastores; S.E. Smith; A.C. Puga; R.M. Lemay; N.J. Weinreb

• Book ID: 116988612
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 241 KB
• Volume: 96
• Category: Article
• ISSN: 1096-7192
• DOI: 10.1016/j.ymgme.2008.12.015